13D/13G Filings - SUTRO BIOPHARMA INC. (STRO)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-17
09:35 am
Purchase
2025-03-3113GSutro Biopharma, Inc.
STRO
BlackRock Inc.
BLK
6,143,608
7.300%
319,686increase
(+5.49%)
Filing
History
2025-04-04
4:32 pm
Purchase
2025-03-2813GSutro Biopharma, Inc.
STRO
RA Capital Management, L.P.4,434,637
5.300%
4,434,637increase
(New Position)
Filing
History
2024-11-14
7:54 pm
Sale
2024-09-3013GSutro Biopharma, Inc.
STRO
Point72 Asset Management, L.P.2,997,453
3.700%
-2,935,455decrease
(-49.48%)
Filing
History
2024-11-14
4:30 pm
Sale
2024-09-3013GSutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P0
0.000%
-3,347,946decrease
(Position Closed)
Filing
History
2024-11-13
4:30 pm
Sale
2024-09-3013GSutro Biopharma, Inc.
STRO
Rubric Capital Management LP0
0.000%
-3,344,810decrease
(Position Closed)
Filing
History
2024-11-12
5:46 pm
Unchanged
2024-09-3013GSutro Biopharma, Inc.
STRO
The Vanguard Group4,195,072
5.110%
0
(Unchanged)
Filing
History
2024-11-12
09:34 am
Purchase
2024-09-3013GSutro Biopharma, Inc.
STRO
Adage Capital Management L.P.2,250,132
2.750%
2,250,132increase
(New Position)
Filing
History
2024-11-04
4:07 pm
Sale
2024-09-3013GSutro Biopharma, Inc.
STRO
Integrated Core Strategies (US) LLC2,031,745
2.500%
-1,420,080decrease
(-41.14%)
Filing
History
2024-11-04
2:09 pm
Purchase
2024-09-3013GSutro Biopharma, Inc.
STRO
The Vanguard Group4,195,072
5.110%
4,195,072increase
(New Position)
Filing
History
2024-04-05
4:05 pm
Purchase
2024-04-0413GSutro Biopharma, Inc.
STRO
Point72 Asset Management, L.P.5,932,908
7.900%
5,932,908increase
(New Position)
Filing
History
2024-02-13
12:16 pm
Purchase
2023-12-3113GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT, LLC5,778,188
9.500%
213,089increase
(+3.83%)
Filing
History
2024-02-12
06:06 am
Purchase
2023-12-3113GSutro Biopharma, Inc.
STRO
Rubric Capital Management LP3,344,810
5.490%
132,938increase
(+4.14%)
Filing
History
2024-02-07
07:56 am
Purchase
2023-12-3113GSutro Biopharma, Inc.
STRO
ADAGE CAPITAL PARTNERS GP L.L.C.4,467,796
7.330%
918,476increase
(+25.88%)
Filing
History
2024-01-24
5:23 pm
Purchase
2023-12-3113GSutro Biopharma, Inc.
STRO
BlackRock Inc.
BLK
5,823,922
9.600%
963,782increase
(+19.83%)
Filing
History
2024-01-17
4:54 pm
Purchase
2024-01-1013GSutro Biopharma, Inc.
STRO
Integrated Core Strategies (US) LLC3,451,825
5.700%
3,451,825increase
(New Position)
Filing
History
2023-10-10
4:52 pm
Purchase
2023-09-2813GSutro Biopharma, Inc.
STRO
ADAGE CAPITAL PARTNERS GP L.L.C.3,549,320
5.860%
3,549,320increase
(New Position)
Filing
History
2023-02-14
3:00 pm
Sale
2022-12-3113GSutro Biopharma, Inc.
STRO
Eventide Asset Management, LLC0
0.000%
-2,708,975decrease
(Position Closed)
Filing
History
2023-02-14
11:45 am
Purchase
2022-12-3113GSutro Biopharma, Inc.
STRO
BIOTECHNOLOGY VALUE FUND L P3,347,946
5.800%
187,530increase
(+5.93%)
Filing
History
2023-02-13
10:56 am
Purchase
2022-12-3113GSutro Biopharma, Inc.
STRO
SUVRETTA CAPITAL MANAGEMENT, LLC5,565,099
9.700%
3,091,304increase
(+124.96%)
Filing
History
2023-02-10
4:00 pm
Purchase
2022-12-3113GSutro Biopharma, Inc.
STRO
Rubric Capital Management LP3,211,872
5.590%
3,211,872increase
(New Position)
Filing
History
Goto 0, 1, 2, Next